TRMU
Mitochondrial tRNA-specific 2-thiouridylase 1
Also known as: FLJ10140, MTO2, MTU1, MTU1_HUMAN, TRMT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75648
- Gene
- TRMU
- Ensembl
- ENSG00000100416
- Chromosome
- 22
- Canonical length
- 421 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This nuclear gene encodes a mitochondrial tRNA-modifying enzyme. The encoded protein catalyzes the 2-thiolation of uridine on the wobble positions of tRNA(Lys), tRNA(Glu), and tRNA(Gln), resulting in the formation of 5-taurinomethyl-2-thiouridine moieties. Mutations in this gene may cause transient infantile liver failure. Polymorphisms in this gene may also influence the severity of deafness caused by mitochondrial 12S ribosomal RNA mutations. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
421 residues, UniProt reviewed canonical sequence.
>O75648|TRMU
1 MQALRHVVCA LSGGVDSAVA ALLLRRRGYQ VTGVFMKNWD SLDEHGVCTA DKDCEDAYRV
61 CQILDIPFHQ VSYVKEYWND VFSDFLNEYE KGRTPNPDIV CNKHIKFSCF FHYAVDNLGA
121 DAIATGHYAR TSLEDEEVFE QKHVKKPEGL FRNRFEVRNA VKLLQAADSF KDQTFFLSQV
181 SQDALRRTIF PLGGLTKEFV KKIAAENRLH HVLQKKESMG MCFIGKRNFE HFLLQYLQPR
241 PGHFISIEDN KVLGTHKGWF LYTLGQRANI GGLREPWYVV EKDSVKGDVF VAPRTDHPAL
301 YRDLLRTSRV HWIAEEPPAA LVRDKMMECH FRFRHQMALV PCVLTLNQDG TVWVTAVQAV
361 RALATGQFAV FYKGDECLGS GKILRLGPSA YTLQKGQRRA GMATESPSDS PEDGPGLSPL
421 LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRMU can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 16 nTPM
- liver: 14 nTPM
- midbrain: 11 nTPM
- kidney: 11 nTPM
- spinal cord: 11 nTPM
- adrenal gland: 11 nTPM
Single-cell type
- cardiomyocytes: 63 nCPM
- distal convoluted tubule cells: 44 nCPM
- myonuclei: 41 nCPM
- cone photoreceptor cells: 39 nCPM
- proximal tubule cells: 36 nCPM
- corticotrophs: 36 nCPM
Immune cell
- T-reg: 11 nTPM
- non-classical monocyte: 9.9 nTPM
- gdT-cell: 9.5 nTPM
- memory CD8 T-cell: 9.1 nTPM
- intermediate monocyte: 9 nTPM
- MAIT T-cell: 8.4 nTPM
Brain region
- midbrain: 5.6 nTPM
- pons: 5.4 nTPM
- thalamus: 5.4 nTPM
- hypothalamus: 5.3 nTPM
- medulla oblongata: 5.3 nTPM
- choroid plexus: 5.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRMU.
Disease | AllUniProt
Conditions TRMU is implicated in, by any mechanism.
- Deafness, aminoglycoside-induced (DFNI) MIM:580000
- Liver failure, infantile, transient (LFIT) MIM:613070
Disease | GeneticClinVar
171 pathogenic / likely-pathogenic of 870 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.56
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.33
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- tRNA binding
- tRNA-5-taurinomethyluridine 2-sulfurtransferase
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Rossmann-like alpha/beta/alpha sandwich fold
- tRNA-specific 2-thiouridylase MnmA-like
- tRNA-specific 2-thiouridylase MnmA-like, central domain superfamily
- tRNA-specific 2-thiouridylase MnmA-like, central domain
- tRNA-specific 2-thiouridylase MnmA-like, C-terminal domain
- tRNA methyl transferase HUP domain
- Aminomethyltransferase beta-barrel domain
- tRNA methyl transferase PRC-barrel domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRMU as an antibody target. Whether an autoantibody or antibody against TRMU could matter depends on whether native TRMU is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRMU is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRMU as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...